Acute exacerbation of airspace enlargement with fibrosis  by Kakugawa, Tomoyuki et al.
lable at ScienceDirect
Respiratory Medicine Case Reports 13 (2014) 19e23Contents lists avaiRespiratory Medicine Case Reports
journal homepage: www.elsevier .com/locate/rmcrCase reportAcute exacerbation of airspace enlargement with ﬁbrosis
Tomoyuki Kakugawa a, Kazuhiro Tabata b, Daiki Ogawara a, Tomoshi Tsuchiya c,
Shintaro Hara a, Noriho Sakamoto a, Yuji Ishimatsu a, *, Kazuto Ashizawa d,
Takeshi Nagayasu c, Junya Fukuoka b, Shigeru Kohno a
a Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
b Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan
c Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
d Department of Clinical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanKeywords:
Acute exacerbation
Airspace enlargement with ﬁbrosis
Smoking-related interstitial lung disease* Corresponding author. Second Department of
University School of Medicine, 1-7-1 Sakamoto, N
Japan. Tel.: þ81 95 819 7273; fax: þ81 95 849 7285.
E-mail addresses: kakugawa@nagasaki-u.ac.jp (T. K
ac.jp (K. Tabata), bomb0416@yahoo.co.jp (D. Ogawara)
(T. Tsuchiya), hara_shin123@me.com (S. Hara),
(N. Sakamoto), yuji-i@nagasaki-u.ac.jp (Y. Ishim
(K. Ashizawa), nagayasu@nagasaki-u.ac.jp (T. Nagaya
jp (J. Fukuoka), s-kohno@nagasaki-u.ac.jp (S. Kohno).
http://dx.doi.org/10.1016/j.rmcr.2014.07.005
2213-0071/© 2014 The Authors. Published by Elseviera b s t r a c t
In 2008, Kawabata et al. described a lesion which they termed “airspace enlargement with ﬁbrosis” that
could be included on the spectrum of smoking-related interstitial lung diseases. This group also reported
that patients with airspace enlargement with ﬁbrosis but without coexisting interstitial pneumonia of
another type had no acute exacerbations and favorable prognoses on clinical follow-up. Here we describe
the ﬁrst case, to our knowledge, of acute exacerbation of airspace enlargement with ﬁbrosis without
coexisting interstitial pneumonia of another type. An 82-year-old man was referred to our department
for worsening dyspnea and new alveolar opacities on chest radiograph following left pulmonary seg-
mentectomy (S6) for cancer. A diagnosis of acute exacerbation of airspace enlargement with ﬁbrosis
without coexisting interstitial pneumonia of other types was made, based on pathological evidence of
airspace enlargement with ﬁbrosis and organizing diffuse alveolar damage. Treatment with high-dose
methylprednisolone followed by tapered oral prednisolone resulted in gradual improvement of the
clinical condition and chest radiographic ﬁndings. Clinicians should be aware that patients with airspace
enlargement with ﬁbrosis may experience acute exacerbation.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Smoking is associated with chronic obstructive pulmonary
diseases and lung cancer. Recently smoking has been implicated as
a cause of interstitial lung disease, in what is called “smoking-
related interstitial lung disease” [1e5]. It has been reported that
pathologically signiﬁcant but clinically unrecognized interstitial
ﬁbrosis occurs commonly in cigarette smokers [1e5]. In 2008,
Kawabata et al. [6] described a lesion which they termed “airspace
enlargement with ﬁbrosis (AEF)” that could be included on the
spectrum of smoking-related interstitial lung diseases. The lesion isInternal Medicine, Nagasaki
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emphysema, and is characterized by a ﬁbrous and frequently hya-
linized interstitium with structural remodeling, but lacking foci of
ﬁbroblasts. These incidental histologic ﬁndings in smokers are not
regarded as a distinct form of idiopathic interstitial pneumonia (IIP)
[5], but AEF includesmore interstitial ﬁbrosis than described for the
classic deﬁnition of emphysema [7]. Yamada et al. [8] suggested
that the histological features of AEF differed signiﬁcantly from
usual interstitial pneumonia (UIP), nonspeciﬁc interstitial pneu-
monia (NSIP), and centrilobular emphysema (CLE) and that the
mechanism of ﬁbrosis of AEF is different from that of UIP and NSIP.
They also reported that patients with AEF but without coexisting
interstitial pneumonia of another type had no acute exacerbations
and favorable prognoses on clinical follow-up [6,8]. They specu-
lated that their observation suggested that the AEF and UIP patterns
might be fundamentally different, perhaps related to the fact that
foci of ﬁbroblasts are not a feature of AEF [6]. However, the natural
disease course of AEF has not been fully understood.
Here we describe an AEF patient without coexisting interstitial
pneumonia of another type in whom the natural disease course
and sequential changes on chest high-resolution computednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. High-resolution computed tomography (HRCT) before the ﬁrst surgery.
HRCT of the chest revealed a nodule in the right lower lobe (A) and ill-deﬁned cen-
trilobular small nodules and ground-glass opacities, in addition to low attenuation
areas and small cysts, in the subpleural areas bilaterally (B).
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ﬁnally experienced acute exacerbation. To our knowledge, this is
the ﬁrst reported case of acute exacerbation of AEF in a patient
without coexisting interstitial pneumonia of another type.Case report
An 82-year-old man was referred to our department for wors-
ening dyspnea and new alveolar opacities on chest radiographFig. 2. High-resolution computed tomography (HRCT) after the ﬁrst surgery. Ground-gl
after the ﬁrst surgery (A), and then gradually changed to consolidation with bronchiectasisfollowing left lung segmentectomy (S6). He was an ex-smoker (20
cigarettes a day for 57 years) who had quit smoking 5 years pre-
viously. He had been diagnosed with squamous cell carcinoma of
the lung 4 years previously and had undergone combined right
middle and lower lobectomies (ﬁrst surgery). Before the ﬁrst sur-
gery, HRCT of the chest revealed ill-deﬁned, centrilobular, small
nodules and ground-glass opacities (GGOs), in addition to low
attenuation areas and small cysts, in the subpleural areas bilaterally
(Fig. 1). However, 20 months after the ﬁrst surgery, GGO appeared
along the subpleural area of the right residual lung on HRCT and
gradually changed to consolidation with bronchiectasis (Fig. 2).
Subsequently, 3 years after the ﬁrst surgery, HRCT revealed a new
nodule in the left lower lobe (S6) that gradually increased in size,
suggesting the possibility of recurrence of the lung cancer. There-
fore, he underwent segmentectomy (S6) of the left lung 4 years
after the ﬁrst surgery. Interstitial opacities were not evident in the
left lung on HRCT 2 months before that second surgery. Consoli-
dationwith bronchiectasis was evident along the subpleural area in
the right residual lung (Fig. 3). The chest radiograph obtained
before the second surgery showed no GGOs in the left lung (Fig. 4).
The patient did not complain of worsening dyspnea before the
second surgery, and the respiratory status was stable before, dur-
ing, and just after that procedure. The patient presented to our
department 10 days after the second surgery complaining of
worsening dyspnea for 2 days. There was no history of exposure to
any infectious, toxic, or environmental agent that could cause
interstitial lung disease. Physical examination revealed that he was
afebrile. Fine crackles were detected bilaterally on chest ausculta-
tion. Results of arterial blood gas analysis on 2 L/min O2 via nasal
cannula were pH 7.468, PaO2 83.9 Torr and PaCO2 36.0 Torr. Labo-
ratory examinations on admission revealed awhite blood cell count
of 12,800/mm3 with 90% neutrophils. C-reactive protein was
elevated (6.43 mg/dL). Serum lactate dehydrogenase level was
elevated (426 IU/L). Serum Krebs von den Lungen-6 (KL-6) and
surfactant protein-D levels were elevated (881 U/mL and 717 ng/
mL, respectively). Anti-nuclear antibody and other autoantibodies
to speciﬁc antigens were all negative. Pneumococcal and Legionella
urinary antigens were negative. Cultures of blood to detect bacteria,
fungi, and mycobacteria were all negative. Results of serological
tests for Mycoplasma pneumoniae, Chlamydophila pneumoniae, and
Chlamydophila psittaci were negative; test results for b-D glucan
and cytomegalovirus antigenwere also negative. Echocardiography
demonstrated no evidence of heart failure. Chest radiograph
showed bilateral GGOs in both lower lung ﬁelds (Fig. 5). HRCT
showed bilateral non-homogenous GGOs with traction bronchiec-
tasis and bronchiolectasis with basilar predominance (Fig. 6). The
left lung S6 segmentectomy tumor specimens contained pleo-
morphic carcinoma that had components of sarcomatoid carci-
noma and adenocarcinoma. The surrounding, uninvolved area had
emphysematous changes with interstitial and peribronchiolar
ﬁbrosis, but without histological features of IIPs, such as UIP or NSIPass opacities appeared along the subpleural area of the right residual lung 20 months
on HRCT: 26 months after the ﬁrst surgery (B); 38 months after the ﬁrst surgery (C).
Fig. 3. High-resolution computed tomography (HRCT) 4 years after the ﬁrst surgery (2 months before the second surgery). HRCT of the chest revealed a new nodule in the left
lower lobe (S6). Interstitial opacities were not evident in the left lung. Consolidation with bronchiectasis was evident along the subpleural area of the right residual lung.
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ﬁbrosis in alveoli and respiratory bronchioles, focal hyaline mem-
branes, epithelial denudation, and focal squamous metaplasia,
suggesting organizing diffuse alveolar damage. Retrospective
analysis of the previous specimens of the right middle and lower
lobes resected during the ﬁrst surgery revealed AEF without any
histological features of IIPs (Fig. 7). Based on these ﬁndings, a
diagnosis of acute exacerbation of AEF was made. The patient was
treated with high-dose methylprednisolone (1 g/day intravenously
for 3 days) followed by oral prednisolone (40 mg/day). Chest HRCT
performed 2 weeks later showed some improvement of the GGOs
(Fig. 8). Oral prednisolone was then tapered off very gradually, by
5 mg/day every 2 weeks to 20 mg/day, and then by 2.5 mg/day
every 2 weeks to 12.5 mg/day. This resulted in a gradual
improvement of the clinical condition and the chest radiographic
ﬁndings. However, chest HRCT revealed a new nodule in the left
lower lobe and left pleural effusion 2 months after the second
surgery, suggesting the possibility of recurrence of lung cancer andFig. 4. Chest radiograph before the second surgery. The chest radiograph before the
second surgery showed no ground-glass opacities in the left lung.malignant left pleural effusion. The patient died 4 months after the
second surgery. There was no further episode of acute exacerbation
of AEF during the clinical course.Discussion
To our knowledge, this is the ﬁrst reported case of acute exac-
erbation of AEF without coexisting IIPs (pure AEF). Acute exacer-
bation of idiopathic pulmonary ﬁbrosis (IPF) can be identiﬁed by an
unexplainable increase in dyspnea symptoms within 1 month of
onset; a deterioration in gaseous exchange indicating hypoxemia;
new radiographic alveolar inﬁltrates; and by ruling out other pos-
sibilities such as infection, pulmonary embolism, pneumothorax, or
heart failure [9]. The present case met these criteria, and diffuse
alveolar damage was observed in the lung specimen resected
during the second surgery, suggesting that the acute exacerbation
process had already begun. Accordingly, this case was thought to be
an acute exacerbation of AEF rather than acute lung injury/acute
respiratory distress syndrome following surgery.
Acute exacerbation of IPF usually progresses rapidly and often
results in a fatal outcome [10,11]. In contrast, the response to theFig. 5. Chest radiograph 10 days after the second surgery. Chest radiograph showed
bilateral ground-glass opacities in the lower lung ﬁelds.
Fig. 6. High-resolution computed tomography (HRCT) 10 days after the second surgery. HRCT of the chest showed bilateral non-homogenous ground-glass opacities with
traction bronchiectasis and bronchiolectasis with basilar predominance.
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The clinical course of the present case suggests that the clinical
manifestations of acute exacerbation of pure AEF are different from
those of acute exacerbation of IPF. Recent data have suggested that
acute exacerbation of IPF may be due to an acceleration of the
underlying ﬁbroproliferative disease process [12,13]. Although theFig. 7. Histopathological ﬁndings (A) Photomicrograph of lung specimen resected during t
indicating airspace enlargement with ﬁbrosis (AEF) (A, Scale bar ¼ 500 mm). (BeF) Photomicr
area consisted of emphysematous changes with interstitial and peribronchiolar ﬁbrosis, indic
respiratory bronchioles (C, Scale bar ¼ 100 mm), focal hyaline membranes (D, Scale bar ¼ 10
Scale bar ¼ 100 mm), suggesting organizing diffuse alveolar damage.precise mechanisms of the acute exacerbation remain uncertain,
the current case suggests that pure AEF could not be categorized
simply as CLE, but could be categorized as interstitial lung disease.
Kawabata et al. [6] speculated that AEF might be a subclinical
manifestation of a lesion that, when more widespread, presents as
clinically apparent interstitial lung disease. They speculated thathe ﬁrst surgery. Emphysematous changes with interstitial and peribronchiolar ﬁbrosis,
ographs of lung specimens resected during the second surgery. The non-tumor resected
ating AEF (B, Scale bar ¼ 1 mm). There are some areas of polypoid ﬁbrosis in alveoli and
0 mm), epithelial denudation (E, Scale bar ¼ 50 mm), and focal squamous metaplasia (F,
Fig. 8. High-resolution computed tomography (HRCT) 2 weeks after the initiation of corticosteroid therapy. HRCT of the chest obtained 2 weeks after initiation of cortico-
steroid therapy showed some improvement of ground-glass opacities.
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CLE, but that ﬁbrosis develops in the former. In the current case,
GGO appeared along the subpleural area of the right residual lung
on HRCT 20 months after the ﬁrst surgery, and this gradually
changed to consolidation with bronchiectasis, which is consistent
with their speculation. However, it is also possible that the HRCT
ﬁndings reﬂected a combination of AEF and other types of inter-
stitial pneumonia, because it was reported that AEF and UIP may
coexist [6]. However, the HRCT ﬁndings of the current casewere not
typical of UIP, and the changes were seen only in the right residual
lung. In addition, histopathological features of the resected lung
from the ﬁrst and second surgeries did not include any evidence of
IIPs. Overdistention of the right residual lung due to the combined
middle and lower lobectomies could cause stress and strain within
the lung and might have accelerated the ﬁbrosis in the right re-
sidual lung only. Therefore, it is conceivable that the current case
manifested the natural disease course of pure AEF, although this is
difﬁcult to prove due to the lack of pathological evidence in the
right residual lung.
In conclusion, here we describe what we believe is the ﬁrst re-
ported case of acute exacerbation of pure AEF. Clinicians should be
aware that any patient with AEF may experience acute
exacerbation.Consent
Because the patient was deceased, written informed consent
was obtained from his wife for publication of this case report and
any accompanying images.Authors' contributions
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